Le Lézard
Classified in: Environment, Science and technology
Subjects: MAV, EXE, ENI, ENP

/R E P E A T -- Media Advisory - Government of Canada reconfirms its commitment to the environment/


OTTAWA, July 17, 2017 /CNW/ - The Honourable Catherine McKenna, Minister of Environment and Climate Change, and the Honourable Scott Brison, President of the Treasury Board, on behalf of the Honourable Jim Carr, Minister of Public Services and Procurement, will announce investments towards innovative technologies that will significantly reduce greenhouse gas emissions in the National Capital Region.

 

Date:

July 18, 2017

Time:

1:30 pm (EDT)

Location:

Confederation Heights Central
Heating and Cooling Plant
501 Heron Road
Ottawa, Ontario

 

Note: Media are asked to arrive by 1 pm. Flat shoes are recommended. Please note that the campus where the plant is located is accessible from Brookfield Road and not from Heron Road. The plant is located on the northeast corner of the campus beside the O-Train station.

Follow us on Twitter

Follow us on Facebook

 

SOURCE Public Services and Procurement Canada


These press releases may also interest you

at 21:30
Rubrik, Inc. today announced the pricing of its upsized initial public offering of 23,500,000 shares of its Class A common stock at a public offering price of $32.00 per share. In addition, Rubrik has granted the underwriters a 30-day option to...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:26
OKX, a leading Web3 technology company, has issued updates for April 24, 2024. OKX DeFi Launches 'zkSwap Bonus Event' Offering Users...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
The Board of Directors of TransAlta Corporation declared a quarterly dividend of $0.06 per common share payable on July 1, 2024 to shareholders of record at the close of business on June 1, 2024. The Board of Directors also declared the following...

at 21:02
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that results from four clinical studies of the company's three key...



News published on and distributed by: